Australia's Polynovo hits 1-1/2-year high on revenue growth
16/01/2023 24:02
** Shares of medical devices maker Polynovo PNV.AX rise as
much as 4.3% to A$2.65, their highest level since July 5, 2021
** Co says it recorded A$27.3 million ($19.03 million) in
sales for the first half of the year, a 67.5% rise
** PNV Chairman David Williams says headcount increases and
new market expansion should support a strong 2H23
** As of last close, PNV up 25.7% YTD
($1 = 1.4347 Australian dollars)
(Reporting by Harshita Swaminathan)
((Harshita.Swaminathan@thomsonreuters.com))